<h1>P.K.L Solution Private Limited Sells 6 Lakh Shares in Vivo Bio Tech Ltd</h1>
M/s. P.K.L Solution Private Limited, a promoter group entity, transferred 6,00,000 equity shares of Vivo Bio Tech Limited on August 21, 2026. The transaction represents a significant move in the shareholding structure of the company.
The shares sold by M/s. P.K.L Solution Private Limited were carried by the company’s promoter group. The sale involved the disposal of 6,00,000 shares, which constituted 2.70% of the total shares/voting capital and 2.05% of the total diluted share/voting capital of Vivo Bio Tech Limited.
Prior to the disposal, the equity share capital of Vivo Bio Tech Limited stood at 2,21,90,628 Equity shares of Rs. 10 each, aggregating Rs. 22,19,06,280.
After the acquisition or sale of the shares, the holding of shares carrying voting rights by M/s. P.K.L Solution Private Limited became Nil.
Shareholding and Capital Structure Details
The transaction details, along with the current capital structure of the company, are summarized below:| Metric | Before the Sale | After the Sale |
|---|---|---|
| Equity Shares Carrying Voting Rights | 2,21,90,628 | 2,21,90,628 |
| Total Value of Equity Shares | Rs. 22,19,06,280 | Rs. 22,19,06,280 |
| Total Diluted Share/Voting Capital | N/A | 2,93,23,111 |
| Total Value of Diluted Capital | N/A | Rs. 29,32,31,110 |
The calculations regarding the total diluted share/voting capital of Vivo Bio Tech Limited after the sale are based on the assumption that pending 6,27,409 convertible equity warrants will be converted into equity shares and Outstanding 63,22,000 ESOPs are exercised in one or more tranches.
VIVOBIOT Stock Price Movement
Shares of Vivo Bio Tech Limited are edging higher to ₹18.90 as of 10:16 AM today, rising by 0.91%. The equity continues to test its 52-week low of ₹18.35 amid volatile trading, with a total traded volume of 14,580 shares recorded so far.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.